Valtruis Team 11/25/24 Valtruis Team 11/25/24

2024 VBC Summit Recap

Read More

Valtruis Team 7/8/24 Valtruis Team 7/8/24

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

Read More

Valtruis Team 5/23/24 Valtruis Team 5/23/24

Atropos Health Raises $33M to Scale the Automation of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

Read More

Valtruis Team 5/21/24 Valtruis Team 5/21/24

Wayspring Secures Minority Investment Led by CVS Health Ventures to Expand Innovative Substance Use Disorder (SUD) Home Program

Read More

Valtruis Team 5/21/24 Valtruis Team 5/21/24

Tuesday Health Launches Revolutionary Supportive Care Solution with $60 Million of Strategic Investment from Healthcare Leaders

Read More

Valtruis Team 3/27/24 Valtruis Team 3/27/24

InStride Health Raises Oversubscribed $30 Million Series B to Expand Access to Best-In-Class Specialty Treatment for Pediatric Anxiety and OCD

Read More

Valtruis Team 10/5/23 Valtruis Team 10/5/23

InStride Health, a Specialty Pediatric Anxiety/OCD Outpatient Treatment Provider, Shares Clinically Meaningful Results in First Annual Outcomes Report

Read More

Valtruis Team 6/1/23 Valtruis Team 6/1/23

Valtruis Launches TailorCare, Providing a Value-Based Care Option for Musculoskeletal (MSK) Patients

Read More

Valtruis Team 3/27/23 Valtruis Team 3/27/23

Wellvana Health Announces $84 Million Capital Raise to Drive Innovation in Value-Based Care Enablement

Read More

Valtruis Team 10/13/22 Valtruis Team 10/13/22

Valtruis Adds Vice President of Data and Analytics to Extend Its Deep Operational Platform in Support of Its Growing Group of Partner Companies Delivering Value-Based Models to the Market

Read More

Valtruis Team 10/3/22 Valtruis Team 10/3/22

InStride Health Providing Virtual Pediatric Anxiety/OCD Treatment Launches with Support from McLean Hospital and Leading Healthcare Investors

Read More

Valtruis Team 8/24/22 Valtruis Team 8/24/22

InterWell Health, Cricket Health, and Fresenius Health Partners Complete Three-Way Merger, Creating Premier, Value-based Kidney Care Provider

Read More

Valtruis Team 6/27/22 Valtruis Team 6/27/22

Valtruis Brings Advanced Healthcare Data Analytics Capabilities Into Its Portfolio With Ursa Health Partnership

Read More

Aaron Mazze 4/21/22 Aaron Mazze 4/21/22

Rachel Winokur Joins Valtruis as Executive Advisor

Read More

Guest User 3/21/22 Guest User 3/21/22

Three-Way Merger Combines Focus on Physician and Patient Engagement with Industry-Leading Technology Platform to Create the Nation's Premier, Value Based Kidney Care Provider

Read More

Valtruis Team 2/24/22 Valtruis Team 2/24/22

Valtruis launches Oncology Care Partners, transforming the care journey for cancer patients and providers

Valtruis (a WCAS company) has launched Oncology Care Partners (OCP), a first-of-its-kind platform of owned and affiliated oncology practices purpose-built to transform cancer care in the United States.

Read More

Aaron Mazze 11/3/21 Aaron Mazze 11/3/21

Centene Sells Majority Stake In U.S.Medical Management

Read More

Valtruis Team 9/28/21 Valtruis Team 9/28/21

Wayspring Announces a $75 million Investment from Valtruis, Centene Corporation, CareSource, HLM Venture Partners, and Other Leading Healthcare Investors

Read More

Valtruis Team 8/5/21 Valtruis Team 8/5/21

Cricket Health Secures $83.5 Million Series B Funding Round Supported by Industry-Leading Clinical Outcomes

Read More

Valtruis Team 8/3/21 Valtruis Team 8/3/21

WCAS Announces the Formation of Valtruis, a Newly Formed Value-Based Care Portfolio Company, with Initial $300 Million Commitment

Valtruis launch announcement.

Read More